CervoMed, Inc. (CRVO)
3.98
-0.06
(-1.49%)
USD |
NASDAQ |
Apr 16, 16:00
3.98
0.00 (0.00%)
After-Hours: 20:00
CervoMed Cash from Financing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Agenus, Inc. | 15.37M |
| Curis, Inc. | -0.119M |
| Plus Therapeutics, Inc. | 2.803M |
| Windtree Therapeutics, Inc. | 7.063M |
| Halozyme Therapeutics, Inc. | 239.52M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.576M |
| Cash from Investing (Quarterly) | 5.374M |
| Free Cash Flow | -23.45M |
| Free Cash Flow Per Share (Quarterly) | -0.7107 |
| Free Cash Flow to Equity (Quarterly) | -6.576M |
| Free Cash Flow to Firm (Quarterly) | -6.576M |
| Free Cash Flow Yield | -65.18% |